PCIG
TMO icon

Partners Capital Investment Group’s Thermo Fisher Scientific TMO Stock Holding History

Partners Capital Investment Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-8,056
Closed -$3.91M – 171
2025
Q3 		$3.91M Hold
8,056
– – 0.16% 76
2025
Q2 		$3.27M Sell
8,056
-10,697
-57% -$4.47M 0.13% 81
2025
Q1 		$9.33M Buy
18,753
+8,774
+88% +$4.75M 0.16% 74
2024
Q4 		$5.19M Sell
9,979
-9,398
-49% -$5.17M 0.14% 61
2024
Q3 		$12M Sell
19,377
-1,111
-5% -$658K 0.19% 59
2024
Q2 		$11.3M Buy
20,488
+8,783
+75% +$5.03M 0.19% 59
2024
Q1 		$6.8M Buy
11,705
+10,464
+843% +$5.87M 0.18% 56
2023
Q4 		$659K Sell
1,241
-113
-8% -$54.7K 0.01% 163
2023
Q3 		$685K Buy
1,354
+560
+71% +$298K 0.02% 160
2023
Q2 		$414K Buy
+794
New +$428K 0.01% 173
2021
Q1 		– Sell
-7,568
Closed -$3.53M – 155
2020
Q4 		$3.53M Buy
+7,568
New +$3.55M 0.1% 96

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Partners Capital Investment Group's TMO Position: Q4 2025 in Review

Partners Capital Investment Group sold out of Thermo Fisher Scientific (TMO) in Q4 2025, closing a stake of 8,056 shares — an estimated $3.91M sold.

Partners Capital Investment Group first reported a position in TMO in Q4 2020 and held it in 11 quarters. The position peaked at $12M in Q3 2024. 2,707 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

  • Partners Capital Investment Group reported no remaining Thermo Fisher Scientific position as of Q4 2025 after selling out during the quarter.
  • Partners Capital Investment Group sold 8,056 Thermo Fisher Scientific shares in Q4 2025, an estimated $3.91M.
  • Partners Capital Investment Group first reported a position in Thermo Fisher Scientific in Q4 2020 and held it in 11 quarters.
  • Partners Capital Investment Group's Thermo Fisher Scientific position peaked at $12M in Q3 2024.
  • 2,707 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on Partners Capital Investment Group's 13F filing for Q4 2025, filed 13 Feb 2026.